Iren [IREN] vs Morgan Stanley [MS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Iren Ltd. wins in 5 metrics, Morgan Stanley wins in 12 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Iren Ltd. | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.13 | 17.31 | Morgan Stanley |
| Price-to-Book Ratio | 6.87 | 2.97 | Morgan Stanley |
| Debt-to-Equity Ratio | 153.02 | 455.75 | Iren Ltd. |
| PEG Ratio | -0.05 | 0.53 | Morgan Stanley |
| EV/EBITDA | 91.98 | N/A | N/A |
| Profit Margin (TTM) | 51.48% | 24.75% | Iren Ltd. |
| Operating Margin (TTM) | -45.84% | 40.62% | Morgan Stanley |
| EBITDA Margin (TTM) | N/A | 40.62% | N/A |
| Return on Equity | 20.53% | 14.42% | Iren Ltd. |
| Return on Assets (TTM) | -1.42% | 1.14% | Morgan Stanley |
| Free Cash Flow (TTM) | $-1.13B | $-20.79B | Iren Ltd. |
| Dividend Yield | N/A | 2.15% | N/A |
| 1-Year Return | 508.04% | 65.29% | Iren Ltd. |
| Price-to-Sales Ratio (TTM) | 22.80 | 4.15 | Morgan Stanley |
| Enterprise Value | $17.87B | $225.65B | Morgan Stanley |
| EV/Revenue Ratio | 23.60 | 3.08 | Morgan Stanley |
| Gross Profit Margin (TTM) | 59.76% | N/A | N/A |
| Revenue per Share (TTM) | $3 | $47 | Morgan Stanley |
| Earnings per Share (Diluted) | $1.44 | $11.04 | Morgan Stanley |
| Beta (Stock Volatility) | 4.31 | 1.18 | Morgan Stanley |
| Short % of Float | 17.44% | 0.00% | Morgan Stanley |
Iren Ltd. vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Iren Ltd. | 1.81% | 2.80% | 14.94% | 35.40% | 71.51% | 42.51% |
| Morgan Stanley | 1.84% | 2.70% | 13.23% | 40.00% | 22.61% | 19.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Iren Ltd. | 508.04% | 1,647.66% | 141.01% | 141.01% | 141.01% | 141.01% |
| Morgan Stanley | 65.29% | 142.98% | 154.54% | 745.67% | 837.54% | 275.57% |
Performance & Financial Health Analysis: Iren Ltd. vs Morgan Stanley
| Metric | IREN | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $17.26B | $299.55B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 38,335,765 | 6,501,123 |
| 90 Day Avg. Volume | 33,500,835 | 6,965,138 |
| Last Close | $60.85 | $217.98 |
| 52 Week Range | $9.52 - $76.87 | $129.66 - $220.60 |
| % from 52W High | -20.84% | -1.19% |
| All-Time High | $76.87 (Nov 05, 2025) | $220.60 (Jun 15, 2026) |
| % from All-Time High | -20.84% | -1.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.59% | 0.16% |
| Quarterly Earnings Growth | 0.59% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.51% | 0.25% |
| Operating Margin (TTM) | -0.46% | 0.41% |
| Return on Equity (TTM) | 0.21% | 0.14% |
| Debt to Equity (MRQ) | 153.02 | 455.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.57 | $64.37 |
| Cash per Share (MRQ) | $9.81 | $379.99 |
| Operating Cash Flow (TTM) | $410.25M | $-95,740,000,000 |
| Levered Free Cash Flow (TTM) | $-1,249,673,600 | $16.25B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.15% |
| Last 12-Month Dividend | N/A | $3.93 |
Valuation & Enterprise Metrics Analysis: Iren Ltd. vs Morgan Stanley
| Metric | IREN (Apr 24, 2026) | MS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.13 | 17.31 |
| Forward P/E | 41.12 | 15.16 |
| PEG Ratio | -0.05 | 0.53 |
| Price to Sales (TTM) | 22.80 | 4.15 |
| Price to Book (MRQ) | 6.87 | 2.97 |
| Market Capitalization | ||
| Market Capitalization | $17.26B | $299.55B |
| Enterprise Value | $17.87B | $225.65B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 23.60 | 3.08 |
| Enterprise to EBITDA | 91.98 | N/A |
| Risk & Other Metrics | ||
| Beta | 4.31 | 1.18 |
| Book Value per Share (MRQ) | $7.57 | $64.37 |
Financial Statements Comparison: Iren Ltd. vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | IREN (2025) | MS (2025) |
|---|---|---|
| Revenue/Sales | 501.02M | 65.97B |
| Cost of Goods Sold | 158.99M | N/A |
| COGS % of Revenue | 31.7% | 0.0% |
| Gross Profit | 342.03M | N/A |
| Gross Margin | 68.3% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 22.12M | N/A |
| Operating Margin | 4.4% | 0.0% |
| EBITDA | 211.58M | N/A |
| EBITDA Margin | 42.2% | 0.0% |
| Pre-Tax Income | 93.50M | 21.95B |
| Pre-Tax Income % of Revenue | 18.7% | 33.3% |
| Income Tax | 6.56M | 4.93B |
| Income Tax % of Revenue | 1.3% | 7.5% |
| Net Income (Profit) | 86.94M | 17.03B |
| Profit Margin | 17.4% | 25.8% |
Balance Sheet & Liquidity Metrics
| Metric | IREN (2025) | MS (2025) |
|---|---|---|
| Cash & Equivalents | 564.53M | 81.31B |
| Total Current Assets | 641.17M | N/A |
| Total Current Assets % of Revenue | 128.0% | 0.0% |
| Total Current Liabilities | 149.35M | N/A |
| Total Current Liabilities % of Revenue | 29.8% | 0.0% |
| Long-Term Debt | 963.83M | 349.39B |
| Long-Term Debt % of Revenue | 192.4% | 529.7% |
| Total Shareholders Equity | 1.82B | 112.65B |
| Retained Earnings | -596.17M | 115.09B |
| Retained Earnings % of Revenue | -119.0% | 174.5% |
| Property, Plant & Equipment | 1.46M | 20.00M |
Cash Flow Statement Comparison
| Metric | IREN (2025) | MS (2025) |
|---|---|---|
| Operating Cash Flow | 336.40M | -95.74B |
| Operating Cash Flow % of Revenue | 67.1% | -145.1% |
| Capital Expenditures | -1.36B | -2.90B |
| Free Cash Flow | -1.13B | -20.79B |
| FCF Margin | -224.9% | -31.5% |
| Debt Repayment | 0 | -99.39B |
| Common Stock Repurchase | N/A | -5.84B |
Short Interest & Institutional Ownership Analysis
| Metric | IREN | MS |
|---|---|---|
| Shares Short | 55.88M | 13,702 |
| Short Ratio | 1.69 | 0.00 |
| Short % of Float | 17.44% | 0.00% |
| Shares Outstanding | 331.76M | 1.58B |
| Float Shares | 302.76M | 1.20B |
| % Held by Insiders | 3.01% | 24.27% |
| % Held by Institutions | 40.88% | 63.01% |
| % Held by Public | 56.11% | 12.72% |
Dividend Analysis & Yield Comparison: Iren Ltd. vs Morgan Stanley
| Metric | IREN | MS |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.93 |
| Last 12-Month Dividend Yield | N/A | 2.15% |
| 3-Year Avg Annual Dividend | N/A | $3.63 |
| 3-Year Avg Dividend Yield | N/A | 0.83% |
| 3-Year Total Dividends | N/A | $10.90 |
| Ex-Dividend Date | N/A | Jan 30, 2026 |